Name | 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) |
Synonyms | Xeljanz CP 690550-10 CP 690500-10 Tofacitinib citrate CP-690550 (Tofacitinib citrate) 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-, (3R,4R)-, citrate (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate |
CAS | 540737-29-9 |
EINECS | 638-826-4 |
InChI | InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1 |
InChIKey | SYIKUFDOYJFGBQ-YLAFAASESA-N |
Molecular Formula | C16H20N6O.C6H8O7 |
Molar Mass | 504.497 |
Melting Point | 201 °C (decomp) |
Solubility | Soluble in DMSO (100 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), DMF (~5 mg/ml) |
Appearance | powder |
Color | white to beige |
Storage Condition | room temp |
MDL | MFCD11616529 |
Use | A selective JAK3 inhibitor |
WGK Germany | 3 |
HS Code | 29335990 |